nudz.cz /
Research /
Preclinical Research Program /
Grants and projects

Grants and projects

Diarylethylamine derivates methoxphenidine and its potential therapeutic benefit for the therapy of treatment resistant depression

AZV (NW24-04-00412)

05/2024 – 12/2027

More Info
Novel cariprazine-derived D2/5-HT3 receptor modulators with potential impact on the treatment of schizophrenia and depressive symptoms

GAČR (24-11191O)

02/2024 – 01/2027

More Info
Development of a receptor biochip for the control and regulation of steroid hormones

TAČR (FW06010206)

03/2023 – 06/2026

More Info
Metabolomic and functional effects of 3α5β neuroactive steroids in perinatal brain damage

GAČR 23-05746S

03/2023 – 12/2025

More Info
Alzheimer´s disease and aging: can mTOR inhibitors kill two birds with one drug?

GAČR 23-05857S

01/2023 – 12/2025

More Info
The pathophysiological alterations in the brain after post-psychotic state and perinatal hypoxia

AZV (NU22J-04-00061)

05/2022 – 12/2025

More Info

Past Grants

Grant name	Grant ID	Duration
Grant name: Use of industrial biotechnology methods for differential diagnostics of neurological diseases	Grant ID: OP (CZ.01.1.02/0.0/0.0/17_176/0015497)	Duration: 07/2019 – 06/2022	More information
Grant name: Novel neuroprotective compounds based on NMDA receptor antagonism and cholinergic stimulation	Grant ID: GAČR 20-12047S	Duration: 01/2020 – 12/2022	More information
Grant name: BrainTech: Innovative technologies for psychiatry and clinical neuroscience	Grant ID: TAČR TP01010062	Duration: 01/2020 – 12/2022	More information
Grant name: Biotechnology research into microbiological spectrum changes to improve cognitive functions, depression and other neuropsychiatric disorders, particularly in the aging population - CleverAge Biota	Grant ID: MPO FV40032	Duration: 05/2019 – 12/2022	More information
Grant name: International mobility of NIMH´s researchers	Grant ID: OP (CZ.02.2.69/0.0/0.0/18_053/0017858)	Duration: 05/2021 – 12/2022	More information
Grant name: PharmaBrain	Grant ID: OP (CZ.02.1.01/0.0/0.0/ 16_025/0007444)	Duration: 01/2018 – 04/2023	More information
Grant name: Role of neuroactive steroids in mechnanism of action of clozapine	Grant ID: AZV (NU20-04-00389)	Duration: 05/2020 – 12/2023	More information
Grant name: Dually acting cognitive enhancers for palliative treatment of Alzheimer´s disease	Grant ID: AZV (NU20-08-00296)	Duration: 05/2020 – 12/2023	More information
Grant name: Restoration of motor function in Parkinson's disease using non-invasive hybrid transcranial neuromodulation	Grant ID: MŠMT (JPND-568-060)	Duration: 01/2021 – 12/2024	More information
Grant name: Role of the orbitofrontal cortex, and its modulation by endocannabinoids, in social withdrawal in schizophrenia	Grant ID: GAČR 22-06943S	Duration: 01/2022 – 12/2024	More information
Grant name: The role of higher sensitivity of interneurons to metabolic stress in the development of schizophrenia	Grant ID: GAČR (22-15096S)	Duration: 01/2022 – 12/2024	More information
Grant name: New biochip and microfluidic diagnostics of circulating biomarkers and pharmacogens in psychiatric and oncological diseases	Grant ID: TAČR (FW03010186)	Duration: 01/2021 – 12/2024	More information

Grants and projects

Diarylethylamine derivates methoxphenidine and its potential therapeutic benefit for the therapy of treatment resistant depression

Novel cariprazine-derived D2/5-HT3 receptor modulators with potential impact on the treatment of schizophrenia and depressive symptoms

Development of a receptor biochip for the control and regulation of steroid hormones

Metabolomic and functional effects of 3α5β neuroactive steroids in perinatal brain damage

Alzheimer´s disease and aging: can mTOR inhibitors kill two birds with one drug?

The pathophysiological alterations in the brain after post-psychotic state and perinatal hypoxia

Past Grants